Antibe Therapeutics (ATE.V) Reports Q2 2017 Interim Financial And Operating Results
11/30/2016 11:17:34 AM
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. ("Antibe") (TSXV:ATE) (OTCQX:ATBPF) filed its financial and operating results on Tuesday, November 29 for the fiscal quarter ended September 30, 2016. The Corporation’s unaudited fiscal Q2 2017 interim consolidated financial statements and MD&A are available on SEDAR.
comments powered by